New Player Joins Search For Effective Huntington's Therapies
LoQus23 Looks To Tackle Neurodegenerative Disease
Executive Summary
Despite recent setbacks for Roche and Wave's respective antisense offerings, both those two firms and a number of other companies are trying a variety of approaches to find a treatment for Huntington's.